Harborside, which has well-established cannabis dispensaries in the San Francisco Bay Area, is expected to start trading on the Canadian Securities Exchange (CSE) in the first week of June.
While the company initially announced its plans to go public in August 2018, the process actually has been about 18 months in the making, CEO Andy Berman told Marijuana Business Daily.
The stock exchange listing had been expected late last year but took longer than expected. Berman declined to provide details on the reasons for the delay.
The company expects to be valued at least at the original planned listing price of roughly 200 million Canadian dollars ($150 million), and it could be “more like $250 million (USD),” Berman said.
Lineage also has a 43,000-square-foot grow facility near Sacramento.
Those facilities will complement Harborside’s two dispensaries in Oakland and San Jose plus its cultivation facilities in Salinas on 47 acres. But the Golden State is uppermost in the company’s mind.
“The plan for the next 12 months is to stay very California-focused,” Berman said.
The company has 34 licenses in California and will receive another seven after the RTO, Berman added.
Harborside reported revenue of roughly CA$50 million in 2017. The company “stayed flat” in 2018, Berman said.
The company is expected to make an official update on its listing process next week.
Nick Thomas can be reached at firstname.lastname@example.org